Difference between revisions of "Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[unchecked revision][unchecked revision]
Line 2,152: Line 2,152:
 
!'''Gene'''
 
!'''Gene'''
 
!'''Author'''
 
!'''Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 
!'''Associate Editor'''
 
!'''Associate Editor'''
 
!Author Content  
 
!Author Content  
 
(Pending or Complete)
 
(Pending or Complete)
−
!Editor Reviewed (Date)
+
!'''Date of Last Editor Review'''
−
!Notes
+
!'''Notes'''
 
|-
 
|-
 
|BCR
 
|BCR
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|8/10/18
 
|
 
|
 
|Complete (8/10/18)
 
|Complete (8/10/18)
Line 2,167: Line 2,175:
 
|ABL1
 
|ABL1
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|4/16/19
 
|
 
|
 
|Complete (4/16/19)
 
|Complete (4/16/19)
Line 2,174: Line 2,186:
 
|RUNX1
 
|RUNX1
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|6/9/19
 
|
 
|
 
|Complete (6/9/19)
 
|Complete (6/9/19)
Line 2,181: Line 2,197:
 
|RUNX1T1
 
|RUNX1T1
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|5/23/19
 
|
 
|
 
|Complete (5/23/19)
 
|Complete (5/23/19)
Line 2,188: Line 2,208:
 
|MYH11
 
|MYH11
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|8/6/18
 
|
 
|
 
|Complete (8/6/18)
 
|Complete (8/6/18)
Line 2,195: Line 2,219:
 
|FLT3
 
|FLT3
 
|Kay Weng Choy
 
|Kay Weng Choy
 +
|
 +
|
 +
|Complete
 +
|
 
|
 
|
 
|Complete (
 
|Complete (
Line 2,202: Line 2,230:
 
|NPM1
 
|NPM1
 
|Kay Weng Choy
 
|Kay Weng Choy
 +
|
 +
|
 +
|Complete
 +
|
 
|
 
|
 
|Complete (
 
|Complete (
Line 2,209: Line 2,241:
 
|TP53
 
|TP53
 
|Kay Weng Choy
 
|Kay Weng Choy
 +
|
 +
|
 +
|Complete
 +
|
 
|
 
|
 
|Complete (
 
|Complete (
Line 2,216: Line 2,252:
 
|DNMT3A
 
|DNMT3A
 
|Kay Weng Choy
 
|Kay Weng Choy
 +
|
 +
|
 +
|Complete
 +
|
 
|
 
|
 
|Complete (
 
|Complete (
Line 2,223: Line 2,263:
 
|CEBPA
 
|CEBPA
 
|Gordana
 
|Gordana
 +
|
 +
|
 +
|Complete
 +
|
 
|
 
|
 
|Complete (
 
|Complete (
Line 2,230: Line 2,274:
 
|IDH1
 
|IDH1
 
|Paul De Fazio
 
|Paul De Fazio
 +
|
 +
|
 +
|Complete
 +
|
 
|
 
|
 
|Complete (
 
|Complete (
Line 2,237: Line 2,285:
 
|IDH2
 
|IDH2
 
|Paul De Fazio
 
|Paul De Fazio
 +
|
 +
|
 +
|Complete
 +
|
 
|
 
|
 
|Complete (
 
|Complete (
Line 2,244: Line 2,296:
 
|PML
 
|PML
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|12/5/18
 
|
 
|
 
|Complete (12/5/18)
 
|Complete (12/5/18)
Line 2,251: Line 2,307:
 
|RARA
 
|RARA
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|8/3/18
 
|
 
|
 
|Complete (8/3/18)
 
|Complete (8/3/18)
Line 2,258: Line 2,318:
 
|ETV6
 
|ETV6
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|6/9/19
 
|
 
|
 
|Complete (6/9/19)
 
|Complete (6/9/19)
Line 2,265: Line 2,329:
 
|KIT
 
|KIT
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|10/1/18
 
|
 
|
 
|Complete (10/1/18)
 
|Complete (10/1/18)
Line 2,272: Line 2,340:
 
|CBFB
 
|CBFB
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|8/2/18
 
|
 
|
 
|Complete (8/2/18)
 
|Complete (8/2/18)
Line 2,279: Line 2,351:
 
|GATA2
 
|GATA2
 
|Kay Weng Choy
 
|Kay Weng Choy
 +
|
 +
|
 +
|Complete
 +
|
 
|
 
|
 
|Complete (
 
|Complete (
Line 2,286: Line 2,362:
 
|PTEN
 
|PTEN
 
|Beth Pitel
 
|Beth Pitel
 +
|
 +
|
 +
|Pending
 +
|
 
|
 
|
 
|Pending
 
|Pending
Line 2,292: Line 2,372:
 
|-
 
|-
 
|MLTT3
 
|MLTT3
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,300: Line 2,384:
 
|MECOM
 
|MECOM
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Pending
 +
|
 
|
 
|
 
|Pending
 
|Pending
Line 2,307: Line 2,395:
 
|FGFR1(FLT2)
 
|FGFR1(FLT2)
 
|Brian Davis
 
|Brian Davis
 +
|
 +
|
 +
|Pending
 +
|
 
|
 
|
 
|Pending
 
|Pending
Line 2,313: Line 2,405:
 
|-
 
|-
 
|KMT2A
 
|KMT2A
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,320: Line 2,416:
 
|-
 
|-
 
|DEK
 
|DEK
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,327: Line 2,427:
 
|-
 
|-
 
|NUP214
 
|NUP214
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,334: Line 2,438:
 
|-
 
|-
 
|RBM15
 
|RBM15
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,341: Line 2,449:
 
|-
 
|-
 
|MKL1
 
|MKL1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,348: Line 2,460:
 
|-
 
|-
 
|DDX41
 
|DDX41
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,355: Line 2,471:
 
|-
 
|-
 
|ANKRD26
 
|ANKRD26
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,362: Line 2,482:
 
|-
 
|-
 
|CUX1
 
|CUX1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,369: Line 2,493:
 
|-
 
|-
 
|TET2
 
|TET2
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,376: Line 2,504:
 
|-
 
|-
 
|EZH2
 
|EZH2
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,383: Line 2,515:
 
|-
 
|-
 
|FOXP1
 
|FOXP1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,390: Line 2,526:
 
|-
 
|-
 
|MYC
 
|MYC
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,397: Line 2,537:
 
|-
 
|-
 
|JAK2
 
|JAK2
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,404: Line 2,548:
 
|-
 
|-
 
|WT1
 
|WT1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,411: Line 2,559:
 
|-
 
|-
 
|CBL
 
|CBL
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,418: Line 2,570:
 
|-
 
|-
 
|NF1
 
|NF1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,425: Line 2,581:
 
|-
 
|-
 
|SUZ12
 
|SUZ12
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,432: Line 2,592:
 
|-
 
|-
 
|ERG
 
|ERG
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,439: Line 2,603:
 
|-
 
|-
 
|EST2
 
|EST2
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,446: Line 2,614:
 
|-
 
|-
 
|RPS14
 
|RPS14
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,453: Line 2,625:
 
|-
 
|-
 
|RB1
 
|RB1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,460: Line 2,636:
 
|-
 
|-
 
|MPL
 
|MPL
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,467: Line 2,647:
 
|-
 
|-
 
|CHGA
 
|CHGA
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,474: Line 2,658:
 
|-
 
|-
 
|CDH1
 
|CDH1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,481: Line 2,669:
 
|-
 
|-
 
|SRSF2
 
|SRSF2
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,488: Line 2,680:
 
|-
 
|-
 
|DNMT1
 
|DNMT1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,495: Line 2,691:
 
|-
 
|-
 
|PRDX2
 
|PRDX2
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,502: Line 2,702:
 
|-
 
|-
 
|ASXL1
 
|ASXL1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,509: Line 2,713:
 
|-
 
|-
 
|MN1
 
|MN1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,516: Line 2,724:
 
|-
 
|-
 
|SF3A1
 
|SF3A1
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,523: Line 2,735:
 
|-
 
|-
 
|EP300
 
|EP300
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,530: Line 2,746:
 
|-
 
|-
 
|JARID2
 
|JARID2
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,536: Line 2,756:
 
|
 
|
 
|-
 
|-
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,543: Line 2,767:
 
|
 
|
 
|-
 
|-
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,550: Line 2,778:
 
|
 
|
 
|-
 
|-
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 2,557: Line 2,789:
 
|
 
|
 
|-
 
|-
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|

Revision as of 13:31, 7 August 2020

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myeloproliferative Neoplasms (MPN) Overview Mark Evans (trainee), Fabiola Quintero-Rivera PENDING Fabiola Quintero-Rivera (FQR)
    Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive Disease Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera Complete FQR
    Chronic Neutrophilic Leukemia (CNL) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera PENDING FQR
    Polycythaemia Vera (PV) Disease Gokce A. Toruner PENDING FQR
    Primary Myelofibrosis (PMF) Disease T. Niroshi Senaratne PENDING FQR
    Essential Thrombocythaemia (ET) Disease Rebecca Smith (trainee) + faculty TBD PENDING FQR
    Chronic Eosinophilic Leukemia, Not Otherwise Specified Disease Mark Evans (trainee), Fabiola Quintero-Rivera PENDING FQR
    Myeloproliferative Neoplasm (MPN), Unclassifiable Disease Mark Evans (trainee)+ Fabiola Quintero-Rivera PENDING FQR
Mastocytosis Overview FQR
    Cutaneous Mastocytosis Disease Thuy Phung PENDING FQR
    Systemic Mastocytosis Disease Shashi Shetty PENDING FQR
    Mast Cell Sarcoma Disease Thuy Phung PENDING FQR
Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 Overview Daynna J.Wolff PENDING FQR
    Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement Disease Jay Alden (trainee) +Daynna J.Wolff Complete FQR
    Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement Disease Christopher Sullivan (trainee) + Daynna J.Wolff Complete FQR
    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement Disease Yanna Ding Complete FQR
    Myeloid/Lymphoid Neoplasms with PCM1-JAK2 Disease Jessica Snider (trainee) + Daynna J.Wolff Complete FQR
Myeloid/Lymphoid Neoplasms with ETV6-JAK2 Disease Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff Complete FQR NON-WHO ENTITY
Myeloid/Lymphoid Neoplasms with BCR-JAK2 Disease Lauren R. Crowson (trainee) + Daynna J. Wolff Complete FQR NON-WHO ENTITY
Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) Overview Linsheng Zhang Complete FQR
    Chronic Myelomonocytic Leukemia (CMML) Disease Linsheng Zhang Complete FQR
    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative Disease Linsheng Zhang Complete FQR
    Juvenile Myelomonocytic Leukemia (JMML) Disease Sarah Rapisardo PENDING FQR
    Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T) Disease Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera PENDING FQR
    Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable Disease Ruth MacKinnon PENDING FQR
Myelodysplastic Syndromes (MDS) Overview Teresa Smolarek? FQR
    Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia Disease Xiaoli Du(trainee) +Teresa Smolarek PENDING FQR
    Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS) Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia Disease Xiaoli Du(trainee)+Teresa Smolarek PENDING FQR
    Myelodysplastic Syndrome (MDS) with Excess Blasts Disease Xiaoli Du(trainee)+Teresa Smolarek PENDING FQR
    Myelodysplastic Syndrome (MDS) with Isolated del(5q) Disease Xiaolin Hu(trainee)+Teresa Smolarek Complete FQR
    Myelodysplastic Syndrome (MDS), Unclassifiable Disease Xiaolin Hu(trainee)+Teresa Smolarek PENDING FQR
    Refractory Cytopenia of Childhood Disease Xiaoli Du(trainee)+Teresa Smolarek PENDING FQR
Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms Overview Daynna Wolff+Daniel Butler (Path Resident) Complete Jennelle Hodge (JH)/ Malini Sathanoori (MS)
Myeloid Neoplasms with Germline Predisposition Overview Ying Zou Complete JH / MS
    Acute Myeloid Leukaemia with Germline CEBPA Mutation Disease Daynna Wolff+Matthew Kilpatrick (Path Resident) PENDING JH / MS
    Myeloid Neoplasms with Germline DDX41 Mutation Disease Fei Yang PENDING JH / MS
    Myeloid Neoplasms with Germline RUNX1 Mutation Disease Malini Sathanoori PENDING JH / MS
    Myeloid Neoplasms with Germline ANKRD26 Mutation Disease Fei Yang PENDING JH / MS
    Myeloid Neoplasms with Germline ETV6 Mutation Disease Ying Zou Complete JH / MS
    Myeloid Neoplasms with Germline GATA2 Mutation Disease Daynna Wolff+ Alexandria Avery (Path Resident) Complete JH / MS
Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities Overview Daynna Wolff+ Dan Wang (trainee) Complete JH / MS
    Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 Disease Christine Bryke Complete JH / MS
    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Disease Christine Bryke Complete JH / MS
    Acute Promyelocytic Leukemia (APL) with PML-RARA Disease Shashi Shetty Complete JH / MS
    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 Disease Shashi Shetty Complete JH / MS
    Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214 Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM Disease Gordana Raca Complete JH / MS Need permission for figure? Update WHO?
    Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1 Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with BCR-ABL1 Disease Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS
    Acute Myeloid Leukemia (AML) with Mutated NPM1 Disease Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS Add WHO reference
    Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA Disease Paul deFazio, MSc + Greg Conboy (Monash Health) Complete JH / MS
    Acute Myeloid Leukemia (AML) with Mutated RUNX1 Disease Daynna Wolff+Iris Martin (Path Resident) Complete JH / MS
Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes Disease Fei Yang Complete JH / MS
Therapy-Related Myeloid Neoplasms Disease Shashi Shetty + Shawn A. Silver (resident) Complete JH / MS Check reference format
Acute Myeloid Leukemia (AML), Not Otherwise Specified Overview Anwar Iqbal Complete JH / MS
    Acute Myeloid Leukemia (AML) with Minimal Differentiation Disease Fabiola Quintero-Rivera and Celeste Eno (fellow) Complete JH / MS
   Acute Myeloid Leukemia (AML) without Maturation Disease Jennelle Hodge Complete JH / MS
    Acute Myeloid Leukemia (AML) with Maturation Disease Jennelle Hodge Complete JH / MS
    Acute Myelomonocytic Leukemia Disease Fei Yang Complete JH / MS
    Acute Monoblastic and Monocytic Leukemia Disease Fei Yang Complete JH / MS
    Pure Erythroid Leukemia Disease Ash Yenamandra Complete JH / MS
    Acute Megakaryoblastic Leukemia (AMKL) Disease Fei Yang Complete JH / MS
    Acute Basophilic Leukemia Disease Ash Yenamandra Complete JH / MS
    Acute Panmyelosis with Myelofibrosis Disease Ying Zou and Jialing Huang (MGP fellow) Complete JH / MS
Myeloid Sarcoma Disease Fabiola Quintero-Rivera Complete JH / MS
Myeloid Proliferations Associated with Down Syndrome Overview Patty Greipp Complete JH / MS Need permission for figure?
    Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome Disease Linda Cooley Complete JH / MS
    Myeloid Leukemia Associated with Down Syndrome Disease Linda Cooley Complete JH / MS
Blastic Plasmacytoid Dendritic Cell Neoplasm Disease Daynna Wolff+Hao Liu (Path Resident) Complete JH / MS
Acute Leukemias of Ambiguous Lineage Overview Hui Chen/ Jennelle Hodge Complete JH / MS
    Acute Undifferentiated Leukemia Disease Shashi Shetty + Amelia Nakanishi (resident) Complete JH / MS Check reference format
    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1 Disease Tracy Tucker Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged Disease Tracy Tucker Complete JH / MS
    Mixed Phenotype Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified Disease Shashi Shetty + Priyatharsini Nirmalanantham (resident) Complete JH / MS Check reference format
    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified Disease Fabiola Quintero-Rivera Complete JH / MS
    ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types Disease ?? JH / MS
    ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS) Disease ?? JH / MS
Acute Myeloid Leukemia (AML) with Mutated FLT3 Disease Kay Weng Choy + Greg Conboy (Monash Health) Complete JH / MS NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with NUP214-ABL1 Disease Daynna Wolff+Jessica Snider (Path Resident) PENDING JH / MS NON-WHO ENTITY
Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6 Disease Daynna Wolff+ Paige Woodham (Path Resident) PENDING JH / MS NON-WHO ENTITY
Precursor Lymphoid Neoplasms Overview Yassmine Akkari (YA)
B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities Overview YA
    B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1     Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged Disease Yassmine Akkari+Nicolas Millan (trainee) PENDING YA
    B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy Disease Ashwini Yenamandra +

Lisa Smith + Yassmine Akkari

Complete YA
    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like Disease Mark G. Evans + Fabiola Quintero-Rivera Complete YA
    B-Lymphoblastic Leukemia/Lymphoma with iAMP21 Disease YA
    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified Disease YA
T-Lymphoblastic Leukemia/Lymphoma Overview YA
Early T-Cell Precursor Lymphoblastic Leukemia Disease YA
NK-Lymphoblastic Leukemia/Lymphoma Disease YA
B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements Disease Helene Bruyere PENDING YA NON-WHO ENTITY
Mature B-Cell Neoplasms Overview Snehal Patel (SP)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Disease Honey Reddi PENDING SP
       Monoclonal B-cell Lymphocytosis Disease Honey Reddi PENDING SP
B-cell Prolymphocytic Leukemia Disease Honey Reddi PENDING SP
Splenic Marginal Zone Lymphoma Disease Snehal Patel Complete SP Malini to review
Hairy Cell Leukemia Disease Snehal Patel Complete SP Malini to review
Splenic B-cell Lymphoma/Leukemia, Unclassifiable Overview Snehal Patel Complete SP Malini to review
    Splenic Diffuse Red Pulp Small B-cell Lymphoma Disease Snehal Patel Complete SP Malini to review
    Hairy Cell Leukemia Variant Disease Snehal Patel Complete SP Malini to review
Lymphoplasmacytic Lymphoma Disease Honey Reddi PENDING SP
   Waldenstrom Macroglobulinemia Disease Honey Reddi PENDING SP
IgM Monoclonal Gammopathy of Undetermined Significance Disease SP
Heavy Chain Diseases Overview SP
    Mu Heavy Chain Disease Disease SP
   Gamma Heavy Chain Disease Disease SP
    Alpha Heavy Chain Disease Disease SP
Plasma Cell Neoplasms Overview Zhenya Tang PENDING SP
   Non-IgM Monoclonal Gammopathy of Undetermined Significance Disease Zhenya Tang PENDING SP
    Plasma Cell Myeloma Disease Zhenya Tang/Huang Mo (trainee) PENDING SP
    Plasma Cell Myeloma Variants Disease Zhenya Tang PENDING SP
    Plasmacytoma Disease Zhenya Tang PENDING SP
    Monoclonal Immunoglobulin Deposition Diseases Overview SP
           Primary Amyloidosis Disease SP
           Light Chain and Heavy Chain Deposition Disease Disease SP
Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome Overview SP
         POEMS Syndrome Disease SP
         TEMPI Syndrome Disease SP
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma) Disease Zhenya Tang & Trainee PENDING SP
Nodal Marginal Zone Lymphoma Disease SP
    Paediatric Nodal Marginal Zone Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) PENDING SP
Follicular Lymphoma Disease Ruthann Pfau PENDING SP
    Testicular Follicular Lymphoma Disease Ruthann Pfau PENDING SP
    In Situ Follicular Neoplasia Disease Ruthann Pfau PENDING SP
    Duodenal-Type Follicular Lymphoma Disease Ruthann Pfau PENDING SP
Paediatric-Type Follicular Lymphoma Disease Ruthann Pfau, Kathleen Schieffer (trainee) PENDING SP
Large B-cell Lymphoma with IRF4 Rearrangement Disease SP
Primary Cutaneous Follicle Centre Lymphoma Disease SP
Mantle Cell Lymphoma Disease Mahsa Khanlari PENDING - due 8/15/20 SP
    Leukemic Non-Nodal Mantle Cell Lymphoma Disease Mahsa Khanlari PENDING - due 8/31/20 SP
    In Situ Mantle Cell Neoplasia Disease Mahsa Khanlari PENDING - due 8/15/20 SP
Diffuse Large B-cell Lymphoma, Not Otherwise Specified Disease Ashwini Yenamandra PENDING Greg Corboy (GC)
T-cell/Histiocyte-Rich Large B-cell Lymphoma Disease GC
Primary Diffuse Large B-cell Lymphoma of the CNS Disease GC
Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type Disease GC
EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
EBV-Positive Mucocutaneous Ulcer Disease GC
Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation Disease GC
    Fibrin-Associated Diffuse Large B-cell Lymphoma Disease GC
Lymphomatoid Granulomatosis Disease GC
Primary Mediastinal (Thymic) Large B-cell Lymphoma Disease GC
Intravascular Large B-cell Lymphoma Disease GC
ALK-Positive Large B-cell Lymphoma Disease GC
Plasmablastic Lymphoma Disease Mark Evans (trainee), Fabiola Quintero-Rivera Complete GC
Primary Effusion Lymphoma Disease GC
HHV8-Associated Lymphoproliferative Disorders Overview GC
   Multicentric Castleman Disease Disease GC
   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
   HHV8-Positive Germinotropic Lymphoproliferative Disorder Disease GC
Burkitt Lymphoma Disease GC
Burkitt-Like Lymphoma with 11q Aberration Disease GC
High-Grade B-cell Lymphoma Overview GC
    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Disease GC
    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS) Disease GC
B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma Disease GC
Mature T- and NK-cell Neoplasms Overview Snehal Patel (SP)
T-cell Prolymphocytic Leukemia Disease Michelle Don PENDING SP
T-cell Large Granular Lymphocytic Leukemia Disease Michelle Don PENDING SP
Chronic Lymphoproliferative Disorder of NK Cells Disease Michelle Don PENDING SP
Aggressive NK-cell Leukemia Disease SP
EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood Overview SP
  Systemic EBV-Positive T-cell Lymphoma of Childhood Disease SP
   Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form Disease SP
    Hydroa Vacciniforme-Like Lymphoproliferative Disorder Disease SP
    Severe Mosquito Bite Allergy Disease SP
Adult T-cell Leukemia/Lymphoma Disease SP
Extranodal NK/T-cell Lymphoma, Nasal Type Disease SP
Intestinal T-cell Lymphoma Overview Sumire Kitahara, Derick Okwan (trainee) PENDING SP
    Enteropathy-Associated T-cell Lymphoma Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma Disease Sumire Kitahara PENDING SP
     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
    Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract Disease Sumire Kitahara, Derick Okwan (trainee) PENDING SP
Hepatosplenic T-cell Lymphoma Disease Michelle Don PENDING SP
Subcutaneous Panniculitis-Like T-cell Lymphoma Disease SP
Mycosis Fungoides Disease SP
Sézary Syndrome Disease SP
Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders Overview SP
    Lymphomatoid Papulosis Disease SP
    Primary Cutaneous Anaplastic Large Cell Lymphoma Disease SP
Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes Overview SP
     Primary Cutaneous Gamma Delta T-cell Lymphoma Disease SP
     Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma Disease SP
     Primary Cutaneous Acral CD8+ T-cell Lymphoma Disease SP
     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder Disease SP
Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS) Disease SP
Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin Overview SP
     Angioimmunoblastic T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) PENDING SP
    Follicular T-cell Lymphoma Disease Ruthann Pfau, Sara Akhavanfard (trainee) PENDING SP
     Nodal Peripheral T-cell Lymphoma with T Follicular Helper Phenotype Disease SP
Anaplastic Large Cell Lymphoma, ALK-Positive Disease Sumire Kitahara PENDING SP
Anaplastic Large Cell Lymphoma, ALK-Negative Disease Sumire Kitahara PENDING SP
Breast Implant-Associated Anaplastic Large Cell Lymphoma Disease Sumire Kitahara PENDING SP
Hodgkin Lymphomas Overview Associate Editor??
Nodular Lymphocyte Predominant Hodgkin Lymphoma Disease
Classic Hodgkin Lymphoma Overview
    Nodular Sclerosis Classic Hodgkin Lymphoma Disease
    Lymphocyte-Rich Classic Hodgkin Lymphoma Disease
    Mixed Cellularity Classic Hodgkin Lymphoma Disease
    Lymphocyte-Depleted Classic Hodgkin Lymphoma Disease
Immunodeficiency-Associated Lymphoproliferative Disorders Overview
Lymphomas Associated with HIV Infection Disease
Post-Transplant Lymphoproliferative Disorders Overview
    Non-Destructive Post-Transplant Lymphoproliferative Disorders Disease
    Polymorphic Post-Transplant Lymphoproliferative Disorders Disease Anna Shestakova (trainee)+,

Fabiola Quintero-Rivera

PENDING
    Monomorphic Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types) Overview
          Monomorphic B-cell PTLD Disease
          Monomorphic T/NK-cell PTLD Disease
    Classical Hodgkin Lymphoma Post-Transplant Lymphoproliferative Disorder Disease
Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders Disease
Histiocytic and Dendritic Cell Neoplasms Overview
Histiocytic Sarcoma Disease
Tumors Derived From Langerhans Cells Overview
   Langerhans Cell Histiocytosis Disease
   Langerhans Cell Sarcoma Disease
Indeterminate Dendritic Cell Tumour Disease
Interdigitating Dendritic Cell Sarcoma Disease
Follicular Dendritic Cell Sarcoma Disease
    Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma Disease
Fibroblastic Reticular Cell Tumor Disease
Disseminated Juvenile Xanthogranuloma Disease
Erdheim-Chester Disease Disease
Gene-Specific Pages
Gene Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Author Content

(Pending or Complete)

Date of Last Editor Review Notes
BCR Brian Davis Complete 8/10/18 Complete (8/10/18)
ABL1 Brian Davis Complete 4/16/19 Complete (4/16/19)
RUNX1 Brian Davis Complete 6/9/19 Complete (6/9/19)
RUNX1T1 Brian Davis Complete 5/23/19 Complete (5/23/19)
MYH11 Brian Davis Complete 8/6/18 Complete (8/6/18)
FLT3 Kay Weng Choy Complete Complete (
NPM1 Kay Weng Choy Complete Complete (
TP53 Kay Weng Choy Complete Complete (
DNMT3A Kay Weng Choy Complete Complete (
CEBPA Gordana Complete Complete (
IDH1 Paul De Fazio Complete Complete (
IDH2 Paul De Fazio Complete Complete (
PML Brian Davis Complete 12/5/18 Complete (12/5/18)
RARA Brian Davis Complete 8/3/18 Complete (8/3/18)
ETV6 Brian Davis Complete 6/9/19 Complete (6/9/19)
KIT Brian Davis Complete 10/1/18 Complete (10/1/18)
CBFB Brian Davis Complete 8/2/18 Complete (8/2/18)
GATA2 Kay Weng Choy Complete Complete (
PTEN Beth Pitel Pending Pending
MLTT3
MECOM Brian Davis Pending Pending
FGFR1(FLT2) Brian Davis Pending Pending
KMT2A
DEK
NUP214
RBM15
MKL1
DDX41
ANKRD26
CUX1
TET2
EZH2
FOXP1
MYC
JAK2
WT1
CBL
NF1
SUZ12
ERG
EST2
RPS14
RB1
MPL
CHGA
CDH1
SRSF2
DNMT1
PRDX2
ASXL1
MN1
SF3A1
EP300
JARID2
Retrieved from "https://ccga.io/index.php?title=Volunteer_Assignments_and_Opportunities&oldid=8661"